Liver S9 fraction isolation involves separating enzyme-rich supernatants from liver homogenates. The isolation procedure involves differential centrifugation. This enables the retention of key metabolic enzymes responsible for drug biotransformation. The S9 fraction is obtained in the supernatant, while the larger cellular debris and organelles get removed from the pellets. High-quality liver S9 fractions are crucial for pharmaceutical research, toxicology testing, etc. Kosheeka, India is leading supplier of S9 fraction for research use. Contact:Visit : https://www.kosheeka.com/Contact...